Ascelia Pharma AB (publ) (ACE.ST)
SEK 3.1
(-2.36%)
SEK 3.1
(-2.36%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -126.79 Million | -125.26 Million | -116.55 Million | -85.52 Million | -36.91 Million | -30.33 Million |
| Net Income | -109.28 Million | -147 Million | -137.94 Million | -93.42 Million | -39.9 Million | -37.55 Million |
| Depreciation & Amortization | 1.04 Million | 1.04 Million | 1.03 Million | 825 Thousand | 62 Thousand | - |
| Deferred income taxes | -15.83 Million | -1.04 Million | -1.03 Million | -825 Thousand | -4.02 Million | - |
| Stock-based compensation | 2.93 Million | 1.62 Million | 5.91 Million | 7.87 Million | 3297.00 | 2.25 Million |
| Change in working capital | -21.83 Million | 14.66 Million | 13.47 Million | -693 Thousand | -2.87 Million | 5.67 Million |
| Other non-cash items | 16.18 Million | 5.45 Million | 1.99 Million | 721 Thousand | 9.82 Million | -709 Thousand |
| Investing Cash Flow | 46 Thousand | -65 Thousand | -38 Thousand | 75.99 Million | -75 Thousand | -75 Million |
| Investments in PPE | 126.79 Million | -65 Thousand | -38 Thousand | -397 Thousand | - | - |
| Acquisitions | 46 Thousand | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | -75 Million |
| Sales/Maturities of investments | - | - | - | 76.38 Million | - | - |
| Other Investing Activities | 47.00 | -130 Thousand | - | 76.38 Thousand | -75 Thousand | - |
| Financing Cash Flow | -936.00 | -1100.00 | 184.87 Million | 92.72 Million | -60 Thousand | 200.24 Million |
| Debt repayment | -906.00 | -1016.00 | -944.00 | -643.00 | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -89 Thousand | -295.00 | -914 Thousand | - | - | - |
| Common Stock Issuance | -30 Thousand | -84 Thousand | 199.08 Million | 98.65 Million | - | 222.05 Million |
| Other Financing Activities | -30.00 | 211.00 | -14.21 Million | -5.92 Million | 200.18 Thousand | -21.8 Million |
| Accounts receivables | 1.62 Million | -1.36 Million | -900 Thousand | 1.69 Million | -4.79 Million | - |
| Accounts payables | -14.35 Million | 9.72 Million | 2.25 Million | -1.22 Million | 902 Thousand | - |
| Inventory | 1.92 Million | 850 Thousand | 2.11 Million | -4.26 Million | 1.00 | - |
| Other working capital | -11.03 Million | 5.45 Million | 10 Million | 3.09 Million | 1.01 Million | - |
| Cash at beginning of period | 149.55 Million | 261.59 Million | 184.68 Million | 108.51 Million | 55.06 Million | 55.06 Million |
| Cash at end of period | 21.85 Million | 149.55 Million | 261.59 Million | 184.68 Million | 108.51 Million | 149.97 Million |
| Capital Expenditure | 126.79 Million | -65 Thousand | -38 Thousand | -397 Thousand | - | - |
| Effect of forex changes on cash | -18 Thousand | 14.38 Million | 8.63 Million | -7.01 Million | -4477.00 | -1000.00 |
| Net cash flow / Change in cash | -127.7 Million | -112.04 Million | 76.91 Million | 76.17 Million | 53.45 Million | 94.9 Million |
| Free Cash Flow | - | -125.32 Million | -116.59 Million | -85.92 Million | -36.91 Million | -30.33 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -13.27 Million | -16.69 Million | -10.59 Million | -109.28 Million | -21.36 Million | -41.79 Million |
| Depreciation & Amortization | - | - | 1049.00 | 1.04 Million | - | - |
| Deferred income taxes | - | - | -1049.00 | -15.83 Million | - | - |
| Stock-based compensation | -1.54 Million | 5.02 Million | 800 Thousand | 2.93 Million | 109 Thousand | 1.05 Million |
| Change in working capital | 2.62 Million | -3.64 Million | -8.69 Million | -21.83 Million | -9.51 Million | -1.74 Million |
| Other non-cash items | -3.27 Million | 7.41 Million | 2.57 Million | 16.18 Million | -262 Thousand | 182 Thousand |
| Investing Cash Flow | - | - | -1000.00 | 46 Thousand | 47 Thousand | - |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | -1000.00 | 46 Thousand | 47 Thousand | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | 47.00 | 47.00 | - |
| Financing Cash Flow | 15.09 Million | 18.91 Million | -220.00 | -936.00 | -234.00 | -253.00 |
| Debt repayment | -15.74 Million | -19.13 Million | -205.00 | -906.00 | -234.00 | -238.00 |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | -34 Thousand | -89 Thousand | - | - |
| Common Stock Issuance | -429 Thousand | - | -15 Thousand | -30 Thousand | - | -15 Thousand |
| Other Financing Activities | -218 Thousand | -1000.00 | -15.00 | -30.00 | - | -15.00 |
| Accounts receivables | 378 Thousand | -1.68 Million | 517 Thousand | 1.62 Million | 1.4 Million | 52 Thousand |
| Accounts payables | 1.57 Million | -433 Thousand | -3.09 Million | -14.35 Million | -1.87 Million | -1.6 Million |
| Inventory | - | - | 1.92 Million | 1.92 Million | - | - |
| Other working capital | 676 Thousand | -1.52 Million | -8.05 Million | -11.03 Million | -9.03 Million | -192 Thousand |
| Cash at beginning of period | 26.54 Million | 21.85 Million | 38.99 Million | 149.55 Million | 70.5 Million | 111.37 Million |
| Cash at end of period | 29.77 Million | 26.54 Million | 21.85 Million | 21.85 Million | 38.99 Million | 70.5 Million |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | 104 Thousand | 819 Thousand | -988 Thousand | -18 Thousand | -290 Thousand | 1.68 Million |
| Net cash flow / Change in cash | 3.23 Million | 4.68 Million | -17.13 Million | -127.7 Million | -31.5 Million | -40.87 Million |
| Free Cash Flow | -11.96 Million | -15.05 Million | -15.92 Million | -126.79 Million | -31.03 Million | -42.3 Million |
3E2
SENA
000957
OWUV
0639
GUNKUL